# Filing Detail

Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950170-23-019140
Filing Date
2023-05-09
Accepted
2023-05-09 07:31:10
Documents
59
Period of Report
2023-03-31

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | 10-Q | tngx-20230331.htm iXBRL | 10-Q | 1972216
2 | EX-31.1 | tngx-ex31_1.htm | EX-31 | 19806
3 | EX-31.2 | tngx-ex31_2.htm | EX-31 | 19728
4 | EX-32.1 | tngx-ex32_1.htm | EX-32 | 9587
5 | EX-32.2 | tngx-ex32_2.htm | EX-32 | 9578
| Complete submission text file | 0000950170-23-019140.txt |  | 7174598

Data Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
6 | XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT | tngx-20230331_def.xml | EX-101.DEF | 155190
7 | XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT | tngx-20230331_lab.xml | EX-101.LAB | 340086
8 | XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT | tngx-20230331_pre.xml | EX-101.PRE | 237277
9 | XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT | tngx-20230331.xsd | EX-101.SCH | 36411
10 | XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT | tngx-20230331_cal.xml | EX-101.CAL | 42267
53 | EXTRACTED XBRL INSTANCE DOCUMENT | tngx-20230331_htm.xml | XML | 1460816

Mailing Address 201 BROOKLINE AVENUE SUITE 901 BOSTON MA 02215
Business Address 201 BROOKLINE AVENUE SUITE 901 BOSTON MA 02215 (857) 320-4900
Tango Therapeutics, Inc. (Filer) CIK: 0001819133 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-39485 | Film No.: 23899989
SIC: 2834 Pharmaceutical Preparations